Judah Frommer Score: 16
Analyst at
Morgan Stanley,
Credit Suisse
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-5.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
40%
6 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
25%
1 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 4 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 4 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
33%
4 W / 8 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
40%
6 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 02, 2026 |
Abivax - ADR
ABVX
|
BUY |
$132.00
Est. +2%
|
$129.69 | $108.16 |
Pending
|
$96.55
-25.6%
|
| May 14, 2026 |
Compass Pathways Plc - ADR
CMPS
|
BUY |
$17.00
Est. +55%
|
$10.94 | $14.76 |
Pending
|
$11.79
+7.8%
|
| May 08, 2026 |
PTC Therapeutics Inc
PTCT
|
BUY |
$94.00
Est. +25%
|
$75.36 | $79.91 |
Pending
|
$76.77
+1.9%
|
| Apr 30, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$119.00
Est. +47%
|
$80.73 | $89.46 |
Pending
|
$85.59
+6.0%
|
| Mar 05, 2026 |
Regenxbio Inc
RGNX
|
BUY |
$17.00
Est. +95%
|
$8.72 | $11.36 |
Pending
|
$7.07
-18.9%
|
| Feb 26, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$123.00
Est. +29%
|
$95.03 | $95.90 |
Pending
|
$85.59
-9.9%
|
| Feb 18, 2026 |
Evommune, Inc.
EVMN
|
BUY |
$54.00
Est. +74%
|
$31.06 | $31.97 |
Pending
|
$19.83
-36.2%
|
| Dec 01, 2025 |
Evommune, Inc.
EVMN
|
BUY |
$36.00
Est. +74%
|
$20.71 | $31.97 |
Pending
|
$19.83
-4.2%
|
| Nov 14, 2025 |
Trevi Therapeutics Inc
TRVI
|
BUY |
$19.00
Est. +63%
|
$11.68 | $16.12 |
Pending
|
$14.67
+25.6%
|
| Jan 11, 2025 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$6.00
Est. +9%
|
$5.52 | $12.34 |
Target Met
|
$9.22
+67.0%
|
| Nov 15, 2024 |
Regenxbio Inc
RGNX
|
BUY |
$22.00
Est. +97%
|
$11.14 | $13.93 |
Miss
|
$7.07
-36.5%
|
| Oct 08, 2024 |
Arcus Biosciences Inc
RCUS
|
BUY |
$35.00
Est. +94%
|
$18.08 | $18.98 |
Miss
|
$24.18
+33.7%
|
| Oct 08, 2024 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
BUY |
$35.00
Est. +43%
|
$24.45 | $18.38 |
Miss
|
$21.69
-11.3%
|
| Oct 15, 2021 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$95.00
Est. +13%
|
$84.19 | - | - |
$15.77
-81.3%
|
| Apr 26, 2021 |
Stoke Therapeutics Inc
STOK
|
BUY |
$58.00
Est. +78%
|
$32.50 | - | - |
$30.00
-7.7%
|
Abivax - ADR
ABVX
Jun 02, 2026
Signal & Target
BUY
$132.00
Start Price
$129.69
Best Price (1Y)
$108.16
Current Price
$96.55
Return
-25.6%
Compass Pathways Plc - ADR
CMPS
May 14, 2026
Signal & Target
BUY
$17.00
Start Price
$10.94
Best Price (1Y)
$14.76
Current Price
$11.79
Return
+7.8%
PTC Therapeutics Inc
PTCT
May 08, 2026
Signal & Target
BUY
$94.00
Start Price
$75.36
Best Price (1Y)
$79.91
Current Price
$76.77
Return
+1.9%
Kymera Therapeutics Inc
KYMR
Apr 30, 2026
Signal & Target
BUY
$119.00
Start Price
$80.73
Best Price (1Y)
$89.46
Current Price
$85.59
Return
+6.0%
Regenxbio Inc
RGNX
Mar 05, 2026
Signal & Target
BUY
$17.00
Start Price
$8.72
Best Price (1Y)
$11.36
Current Price
$7.07
Return
-18.9%
Kymera Therapeutics Inc
KYMR
Feb 26, 2026
Signal & Target
BUY
$123.00
Start Price
$95.03
Best Price (1Y)
$95.90
Current Price
$85.59
Return
-9.9%
Evommune, Inc.
EVMN
Feb 18, 2026
Signal & Target
BUY
$54.00
Start Price
$31.06
Best Price (1Y)
$31.97
Current Price
$19.83
Return
-36.2%
Evommune, Inc.
EVMN
Dec 01, 2025
Signal & Target
BUY
$36.00
Start Price
$20.71
Best Price (1Y)
$31.97
Current Price
$19.83
Return
-4.2%
Trevi Therapeutics Inc
TRVI
Nov 14, 2025
Signal & Target
BUY
$19.00
Start Price
$11.68
Best Price (1Y)
$16.12
Current Price
$14.67
Return
+25.6%
4D Molecular Therapeutics Inc
FDMT
Jan 11, 2025
Signal & Target
BUY
$6.00
Start Price
$5.52
Best Price (1Y)
$12.34
Current Price
$9.22
Return
+67.0%
Regenxbio Inc
RGNX
Nov 15, 2024
Signal & Target
BUY
$22.00
Start Price
$11.14
Best Price (1Y)
$13.93
Current Price
$7.07
Return
-36.5%
Arcus Biosciences Inc
RCUS
Oct 08, 2024
Signal & Target
BUY
$35.00
Start Price
$18.08
Best Price (1Y)
$18.98
Current Price
$24.18
Return
+33.7%
Bicara Therapeutics Inc. Common Stock
BCAX
Oct 08, 2024
Signal & Target
BUY
$35.00
Start Price
$24.45
Best Price (1Y)
$18.38
Current Price
$21.69
Return
-11.3%
Sarepta Therapeutics Inc
SRPT
Oct 15, 2021
Signal & Target
BUY
$95.00
Start Price
$84.19
Best Price (1Y)
-
Current Price
$15.77
Return
-81.3%
Stoke Therapeutics Inc
STOK
Apr 26, 2021
Signal & Target
BUY
$58.00
Start Price
$32.50
Best Price (1Y)
-
Current Price
$30.00
Return
-7.7%